Published in Verh Dtsch Ges Rheumatol on January 01, 1976
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol (1999) 5.02
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA (1998) 3.03
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Plant nuclear gene knockout reveals a role in plastid division for the homolog of the bacterial cell division protein FtsZ, an ancestral tubulin. Proc Natl Acad Sci U S A (1998) 2.50
Retracted HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Clin Invest (2000) 2.17
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses. Am J Pathol (1999) 1.78
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis (2001) 1.78
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology (1995) 1.72
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis (2003) 1.64
Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth (2010) 1.59
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol (1991) 1.49
Prediction of creatinine clearance from serum creatinine in patients with rheumatoid arthritis: comparison of six formulae and one nomogram. Clin Rheumatol (2000) 1.46
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol (1997) 1.42
A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. Hum Immunol (1993) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol (1997) 1.39
Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum (1999) 1.39
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer (2013) 1.38
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism (1999) 1.33
Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc Natl Acad Sci U S A (1992) 1.29
Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum (1991) 1.28
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect (2012) 1.19
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions. J Virol (1996) 1.16
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics (1993) 1.15
Postmarketing experience with auranofin in the Federal Republic of Germany. Scand J Rheumatol Suppl (1986) 1.13
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study. Arthritis Rheum (2003) 1.11
Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J Virol (1998) 1.10
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09
Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens (1983) 1.08
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Salt dependence, kinetic properties and catalytic mechanism of N-formylmethanofuran:tetrahydromethanopterin formyltransferase from the extreme thermophile Methanopyrus kandleri. Eur J Biochem (1992) 1.07
MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens (2001) 1.05
Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System. Nat Genet (1997) 1.05
Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. Scand J Rheumatol (2004) 1.03
Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03
Nomenclature for factors of the HLA system, 1990. Hum Immunol (1991) 1.01
[Genetic transmission of HLA dependent disposition for celiac disease]. MMW Munch Med Wochenschr (1980) 1.01
Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens (1986) 0.99
Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis (1992) 0.99
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol (2001) 0.98
HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement. Ann Rheum Dis (1985) 0.97
An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96
MICA sequences 2000. Immunogenetics (2001) 0.95
Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet (1992) 0.95
Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol (2001) 0.95
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol (1996) 0.94
Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum (1996) 0.94
Segregation analysis of HL-A antigens and haplotypes in 50 families of patients with coeliac disease. Transplant Proc (1973) 0.94
A comprehensive search for segregation distortion in HLA. Hum Immunol (1987) 0.94
Nomenclature for factors of the HLA system, 1991. Hum Immunol (1992) 0.93
Results after laparoscopic lysis of adhesions and placement of seprafilm for intractable abdominal pain. Surg Endosc (2002) 0.92
Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis (2001) 0.92
Early-onset pauciarticular juvenile chronic arthritis is associated with a mutation in the Y-box of the HLA-DQA1 promoter. Tissue Antigens (1995) 0.92
Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients. J Mol Med (Berl) (1995) 0.91
Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2'-3'-dideoxy-uridinetriphosphate-labeled oligonucleotide probes. Hum Immunol (1991) 0.91
Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum (1993) 0.91
Linkage group HL-A-MLC-BF (properdin factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6. Humangenetik (1975) 0.91
Deduction of 2140 HL-A haplotypes and segregation analysis in 535 families. Transplant Proc (1973) 0.91
Nomenclature for factors of the HLA System, 1998. Hum Immunol (1999) 0.91
Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol (1994) 0.91
Genetics of insulin dependent diabetes mellitus in Israel: population and family study. Hum Immunol (1981) 0.89
DR2-negative narcolepsy. Lancet (1986) 0.89
Epizootic hemorrhagic disease: analysis of tissues by amplification and in situ hybridization reveals widespread orbivirus infection at low copy numbers. J Virol (1998) 0.89
The nasal airflow in noses with septal perforation: a model study. ORL J Otorhinolaryngol Relat Spec (2005) 0.89
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scand J Rheumatol (2001) 0.89
Hemarthrosis after trauma to the pediatric knee joint: what is the value of magnetic resonance imaging in the diagnostic algorithm? J Pediatr Orthop (2001) 0.88
Nomenclature for factors of the HLA system, 2000. Hum Immunol (2001) 0.88
HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility. Immunol Rev (1983) 0.88
Management of kidney injuries in children with blunt abdominal trauma. J Pediatr Surg (2000) 0.88
[Prerequisites for a new health care model for elderly people with multiple morbidities: results and conclusions from 3 years of research in the PRISCUS consortium]. Z Gerontol Geriatr (2011) 0.88
A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis. Br J Rheumatol (1996) 0.87
Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics (1993) 0.86
HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics (1993) 0.86
Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses. J Virol (1989) 0.86
Nomenclature for factors of the HLA System, 1996. Hum Immunol (1997) 0.86
A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes. J Virol (1993) 0.86
High serum IgE concentrations: association with HLA-DR and markers on chromosome 5q31 and chromosome 11q13. J Allergy Clin Immunol (1997) 0.86